A
Allergic contact eczema 116
cosmetics 119
drug vehicles 119
metals 119
pharmaceutical products 117
plant materials 120
preservative agents 119
rubber additives 119
Allergy hypersensitivity 153
Angioedema 115
Angiogenesis 82
Anterior chamber associated immune deviation (ACAID) 108
Antigen-presenting cells 43
Atopic aczema 120
Atopic dermatitis 138
B
involvement in allergic eye disorders 81
mediators 78
membrane receptors 80
morphologic and ultrastructural characteristics 77
pharmacologic modulation 83
adenylate cyclase activators 84
blockade of activating receptors 83
glucocorticoids 84
immunophilin ligands 84
inhibition of signal transduction 83
phosphodiesterase inhibitors 84
receptor antagonists 85
role for allegic angiogenesis 82
surface markers 79
C
Chemosis 180
Cicatricial conjunctivitis 182
Contact urticaria 116
Corneal allograft rejection 184
adoptive transfer of graft rejection 189
atopy as risk factors 184
TH2-mediated airway hyperreactivity 186
Cortisone 202
E
Environment and allergy 95
adjuvant effects of air pollutants 98
air pollutants 99
causative factors in development 95
genetic and environmental determinants 96
influence of air pollutants in allergic bioavailability 96
I
Immunoglobulin E (IgE) 20
diseases related to 130
inert nature of IgE binding 23
effect of monomeric IgE 27
pathophysiology 20
relevance of monomeric IgE 30
requirement of aggregation 23
specific IgE 173
intercellular adhesion molecule (ICAM) 168
M
Mast cell stabilizers 202
activated 6
degranulation 78
development 4
functions 144
immune responses to non-bacterial pathogens 145
induction of innate immune responses to bacterial infections 144
granule protease proteoglycan complex 2
histochemistry 2
immune responses to pathogens 147
innate immune system 130
morphology 2
proteases (MCP) 2
react to environmental threats 145
receptors 6
skin mast cells 143
tryptase mediators 9
O
Ocular allergy 178
differential diagnosis 179
chemosis 180
cicatricial conjunctivitis 182
conjunctival congestion 181
corneal ulcer 183
lid swelling 180
limbal mass 180
pannus 181
proteases 173
pseudomembranous conjunctivitis 181
Reaction in ocular allergy 167
early-and late-phase 167
TH1-and TH2-type cytokines 169
epidemiology management 163
Omalizumab (see also “anti-IgE”) 39